Apollomics (APLM) Prepaid Assets (2021 - 2025)

Apollomics (APLM) reported Prepaid Assets of $470000.0 for Q4 2025, down 82.96% quarter-over-quarter from $2.8 million in Q2 2023.

Apollomics (APLM) Prepaid Assets (2021 - 2025) Analysis & Trends

Apollomics (APLM) has 4 years of Prepaid Assets data on file, last reported at $470000.0 in Q4 2025.

  • Prepaid Assets for Q4 2025 came in at $470000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $470000.0 (changed N/A YoY), and the FY2025 annual result was $470000.0, changed N/A from the prior year.
  • Prepaid Assets declined to $470000.0 in Q4 2025 per APLM's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $4.8 million in Q4 2021 and troughed at $470000.0 in Q4 2025.
  • A 4-year average of $2.3 million and a median of $2.0 million in 2022 frame the typical range for Prepaid Assets.
  • On a YoY basis, Prepaid Assets climbed as much as 75.64% in 2022 and fell as far as 75.64% in 2022.
  • A 4-year view of Prepaid Assets shows it stood at $4.8 million in 2021, then slumped by 75.64% to $1.2 million in 2022, then soared by 134.61% to $2.8 million in 2023, then plunged by 82.96% to $470000.0 in 2025.
  • Business Quant data shows APLM's Prepaid Assets at $470000.0 in Q4 2025, $2.8 million in Q2 2023, and $1.2 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Apollomics 294.00 Mn 294.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 470,000.00
Jun 30, 2023 2.76 Mn
Dec 31, 2022 1.18 Mn
Dec 31, 2021 4.83 Mn